Immuno oncology

The most recent energizing examination leap forward for disease treatment is in the field of immuno-oncology. This type of treatment uses or upgrades the patient's own particular insusceptible framework to have the capacity to stop the development of malignancy cells.

The insusceptible framework is the body's common barrier framework. It is an accumulation of organs, cells and exceptional atoms that shields you from contaminations, tumor and different maladies. At the point when an alternate (remote) life form goes into the body, for instance a microscopic organisms, the resistant framework remembers it and after that assaults it, keeping it from creating hurt. This procedure is called an insusceptible reaction. Since malignancy cells are altogether different from typical cells in the body, the resistant framework assaults them when it can remember them. Notwithstanding, disease cells regularly discover approaches to mask themselves as typical cells, so that the safe framework does not generally remember them as unsafe. What's more, like infections, they can change after some time (transform) and hence escape from the insusceptible reaction. Additionally, the characteristic safe reaction to disease cells is frequently not sufficiently solid to battle off growth cells. Immuno-oncology treatments enact our insusceptible framework, making it ready to perceive growth cells and decimate them.

  • Tumor immunology
  • Immuno-resistive drugs
  • Antibody and protein engineering
  • Biomarker discovery
  • Immunology
  • Cell and gene therapy
  • Preclinical and clinical development
  • Prediction and Prognosis in Immunotherapy
  • Enhancing Adaptive Anti-Tumor Responses
  • Tumour microenvironment
  • Tumour-associated antigens
  • Antitumour
  • Immune suppression
  • Immunosurveillance

Related Conference of Immuno oncology

April 24-25, 2017

16th Global Annual Oncologists Meeting

Dubai, UAE
May 25-27, 2017

Global Summit on Oncology & Cancer

Osaka, Japan
September 18-19, 2017

International Conference on Cancer Biology R&D and Market

Philadelphia, Pennsylvania, USA
June 29-July 01, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
July 20-21, 2017

3rd Annual Conference on Gynecologic Oncology

Chicago, Illinois, USA
July 20-21, 2017

World Congress on Preventive Oncology

Chicago, Illinois, USA
August 28-30, 2017

Oncologist & Diagnostics Conference

Brussels, Belgium
October 23-25, 2017

World Cancer Meeting

Seoul , South Korea
October 9-10, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany
November 16-17, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27-28, 2017

Annual World Congress on Biomarkers & Clinical Research

Atlanta, Georgia, USA
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE

Immuno oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in